Chimerix: Potential 'First' In Targeting Recurrent High-Grade Glioma Patients
Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...
Hosted on MSN1d
Purple Biotech advances NT219 into Phase II recurrent/metastatic SCCHN study
Purple Biotech has entered a Phase II trial with its small molecule drug, NT219, focusing on patients with ...
Marine Log1d
Elomatic awarded Polarstern 2 icebreaker design contract
Thyssenkrupp Marine Systems (TKMS) has awarded Elomatic Maritime Technologies GmbH a design and engineering contract to ...
Monthly Prescribing Reference1d
Zongertinib Under Review for HER2-Mutant Advanced NSCLC
The Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application for zongertinib for the treatment of adult patients with ...
BioSpace1d
Gilead Passes on Option for Arcus’ Cancer Drug Despite Strong Early Data
The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective ...
Chemomab completes End-of-Phase 2 Meeting with the FDA for CM-101
Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...
Kashmir Reader2d
Insufficient Snow Forces Postponing Of KIWG In Gulmarg
Gulmarg: The second leg of the 5th Khelo India Winter Games, scheduled to begin here on Saturday, has been postponed due to insufficient snowfall in the region.
Khelo India Winter Games Second Leg Postponed Due To Insufficient Snow In Gulmarg
The second leg of the 5th Khelo India Winter Games, scheduled to begin in Gulmarg on Saturday, has been postponed due to ...
Polygon6d
Everything we know about Switch 2, Nintendo’s next-gen console
Also, Nintendo Switch 2 launches into a changed market where players have come to expect that they will be able to carry their game libraries forward from one machine to another, which precluded a ...